Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dopexamine and Norepinephrine vs Epinephrine in Septic Shock
NCT00134212Phase 2Completed
- Sponsor
- CHU Rennes
- Start
- Mar 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised trial of dopexamine in septic shock (2 arms), sponsored by CHU Rennes. Primary endpoint: Gastric Mucosal Blood Flow. Started Mar 2002; status: completed.
02
Drugs
dopexamine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT00134212.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00134212.